A key global player in ingredients developed from fermentation, Gnosis by Lesaffre expands its reach for Mood & Cognitive Health solutions in 2023 with a new production line expansion dedicated to its star ingredient: Adonat® Premium SAMe (S-Adenosyl-L-Methionine).
SAMe is a natural molecule supporting healthy mood and emotional well-being since it is directly involved in the neurotransmitter’s synthesis. It also sustains cognitive functions, being one of the most important factors studied counteracting alterations in brain structures and functions, intimately tied to the aging process. Further, SAMe applies to supporting liver and joint health.
An aging global population, the rise in neurodegenerative diseases, the COVID-19 pandemic, and the most recent phenomenon of digital dementia have amplified consumer demand for SAMe, increasing the traction for brain & mood health solutions. To that end, Gnosis, the key SAMe manufacturer, was motivated to pursue new opportunities for growth and best serve our partners.
Latest news & videos
- MenaQ7®
- Mobility & Joint
- News
- May 21, 2025
K2SAC’s 4th Meeting Showcases New Clinical Insights and Emerging Talent in Vitamin K2 Research
On May 12-13, the 4th Gnosis Vitamin K2 Scientific Advisory Committee meeting convened leading...
- Adonat®
- Digestion & Gut
- Mobility & Joint
- May 13, 2025
Adonat® Premium SAMe: Your Go-To Brain-Health Solution Through Adulthood
A short, dynamic video dedicated to S-Adenosyl-Methionine benefits, part of a new educational series,...
- News
- Quatrefolic®
- Wellness & Immune
- May 12, 2025
The New Quatrefolic® Liquid Formulation Solution
The global market for liquid dietary supplements is experiencing steady growth, driven by increasing...
